West China cattle skeletal muscle related circular RNA circCOQ3 and application thereof

By identifying and applying circular RNA circCOQ3 related to West China bovine skeletal muscle, the gap in the research on the muscle development mechanism of West China bovine was solved, and the regulation of West China bovine skeletal muscle cell proliferation and cell cycle was achieved, and new breeding targets were provided. Promote the improvement of beef cattle breeds and the improvement of beef quality.

CN119020362AActive Publication Date: 2024-11-26INST OF ANIMAL SCI & VETERINARY MEDICINE SHANDONG ACADEMY OF AGRI SCI
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202411449569.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-10-17
Publication Date
2024-11-26
Estimated Expiration
2044-10-17

AI Technical Summary

Technical Problem

There is a lack of in-depth research on the skeletal muscle development mechanism of West China cattle in the existing technology, especially the differential expression of circRNA in the muscle development of West China cattle has not been fully explored, which has affected the improvement of beef cattle breeds and the development of animal husbandry.

Method used

Identification and application of circular RNA circCOQ3 related to West China bovine skeletal muscle is used to regulate the proliferation and cell cycle of West China bovine skeletal muscle cells by designing primers and inhibitors to detect and inhibit circCOQ3, and provide new breeding targets.

Benefits of technology

It successfully regulates the proliferation efficiency of bovine skeletal muscle cells, provides a new target for West China cattle biological breeding, and promotes the improvement of beef breeds and the improvement of beef quality.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119020362A_ABST
    Figure CN119020362A_ABST
Patent Text Reader

Abstract

The invention relates to a western China cattle skeletal muscle related circular RNA circCOQ3 and application thereof, and belongs to the technical field of zoology. In the detection of skeletal muscle development, the circCOQ3 shows different expression quantities in different development stages. Along with development, the expression quantity of circCOQ3 is obviously reduced. A further functional research shows that the cell cycle can be obviously influenced by interference of circCOQ3, so that the proliferation efficiency of the bovine skeletal muscle cells is further reduced. The discovery provides a new theoretical basis for improving the beef quality of the Chinese cattle, and lays a foundation for application of circCOQ3 as a new target in biological breeding of the Chinese cattle.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of zoology, and in particular relates to a Huaxi cattle skeletal muscle-related circular RNA circCOQ3 and an application thereof. Background Art

[0002] "Huaxi Cattle" is a new breed of specialized beef cattle with core industry competitiveness and international market competitiveness. It has the characteristics of fast growth rate, high slaughter rate and net meat rate, good reproductive performance, strong resistance to adversity, and has a high market share. In beef cattle production, growth and development rate is one of the most important economic traits. Skeletal muscle is the most important component of the body, and the growth and development of skeletal muscle directly affects the yield and quality of beef. Therefore, exploring the laws of skeletal muscle development of Huaxi cattle and analyzing the molecular mechanisms that regulate its development will provide theoretical and technical support for the improvement of beef cattle breeds and promote the high-quality development of animal husbandry.

[0003] As an important component of the body, skeletal muscle plays a key role in maintaining body balance and basal metabolism. The generation of skeletal muscle depends on myogenesis after birth. It is a highly coordinated process, including the determination of multipotential mesoderm cells, the proliferation and migration of myoblasts, the fusion of myocytes into multinucleated myofibers, and the maturation of myofibers. This process is controlled by multiple genes, such as MRFs (myogenic regulator factors), MEF2 (myocyte enhance factor 2), and PAX (Paired box) gene families. At the same time, non-coding RNAs (ncRNAs), such as microRNAs (miRNAs), long noncoding RNAs (lncRNAs), and circular RNAs (circRNAs) are considered to be important regulatory factors for skeletal muscle development and regeneration. At present, researchers have identified a large number of circRNAs that regulate skeletal muscle growth and development in different cattle breeds, and have analyzed the molecular mechanisms of some circRNAs in regulating muscle development. It is worth noting that the circRNAs that regulate muscle growth and development are different between different breeds, and there is a certain breed specificity. As a new breed of beef cattle independently bred in my country, there are few reports on the study of circRNA regulating muscle development using Huaxi cattle as a material. Therefore, exploring the differentially expressed circRNAs in the muscle development of Huaxi cattle will provide new targets for the biological breeding of Huaxi cattle. Summary of the invention

[0004] The purpose of the present invention is to provide a circular RNA circCOQ3 associated with skeletal muscle of Huaxi cattle and its application. , thereby providing a new target for biological breeding of Huaxi cattle. To achieve the above purpose, the present invention provides the following technical solutions:

[0005] First, the present invention provides a circular RNA related to skeletal muscle development of Huaxi cattle, wherein the circular RNA is circCOQ3, the transcript sequence of the circCOQ3 is shown in SEQ ID NO.1, and the connecting gene sequence of the circCOQ3 is shown in SEQ ID NO.2.

[0006] Secondly, the present invention provides the use of primers for detecting the expression of circular RNA circCOQ3 in preparing a kit for detecting the skeletal muscle development stage of Huaxi cattle, wherein the transcript sequence of circCOQ3 is shown in SEQ ID NO.1, and the connecting gene sequence of circCOQ3 is shown in SEQ ID NO.2;

[0007] The sequences of the primers are shown in SEQ ID NO.3 and SEQ ID NO.4.

[0008] Preferably, the Huaxi cattle skeletal muscle is the longissimus dorsi muscle of Huaxi cattle.

[0009] Preferably, the expression level of circular RNA circCOQ3 in the skeletal muscle of newborn Huaxi cattle is the highest, and the expression level of circular RNA circCOQ3 in the skeletal muscle of adult Huaxi cattle is the lowest.

[0010] Secondly, the present invention provides an inhibitor that interferes with the expression of circular RNA circCOQ3 for use in preparing a Huaxi cattle skeletal muscle improvement breeding regulator, the transcript sequence of the circCOQ3 is shown in SEQ ID NO.1, and the connection gene sequence of the circCOQ3 is shown in SEQ ID NO.2.

[0011] Preferably, the inhibitor is siRNA, the sense strand sequence of the siRNA is shown in SEQ ID NO.11, and the antisense strand sequence of the siRNA is shown in SEQ ID NO.12.

[0012] Preferably, the inhibitor regulates the skeletal muscle improvement breeding of Huaxi cattle by regulating the proliferation of skeletal muscle cells of Huaxi cattle.

[0013] Secondly, the present invention provides an inhibitor that interferes with the expression of circular RNA circCOQ3 for use in the preparation of an inhibitor for inhibiting the proliferation of Huaxi cattle skeletal muscle cells, wherein the transcript sequence of circCOQ3 is shown in SEQ ID NO.1, and the connecting gene sequence of circCOQ3 is shown in SEQ ID NO.2;

[0014] The inhibitor is siRNA, the sense strand sequence of the siRNA is shown in SEQ ID NO.11, and the antisense strand sequence of the siRNA is shown in SEQ ID NO.12.

[0015] Secondly, the present invention provides an inhibitor that interferes with the expression of circular RNA circCOQ3 in the preparation of a preparation for regulating the cell cycle of Huaxi cattle skeletal muscle cells, wherein the transcript sequence of circCOQ3 is shown in SEQ ID NO.1, and the linked gene sequence of circCOQ3 is shown in SEQ ID NO.2;

[0016] The inhibitor is siRNA, the sense strand sequence of the siRNA is shown in SEQ ID NO.11, and the antisense strand sequence of the siRNA is shown in SEQ ID NO.12;

[0017] The cell cycle inhibitor leads to a significant upregulation of the cell cycle inhibitory gene CDKN1A and a significant downregulation of the cell cycle promoting genes Cyclin D1 and PCNA.

[0018] Secondly, the present invention provides a method for inhibiting the proliferation of skeletal muscle cells of Huaxi cattle, the method comprising the following steps:

[0019] (1) Inoculating Huaxi cattle skeletal muscle cells into a cell culture device, placing them in a cell culture incubator, and culturing them until they adhere to the wall;

[0020] (2) Transfecting siRNA of circular RNA circCOQ3 into cells and continuing to culture them in a cell culture incubator can inhibit the proliferation of Huaxi cattle skeletal muscle cells;

[0021] The transcript sequence of circCOQ3 is shown in SEQ ID NO.1, and the connecting gene sequence of circCOQ3 is shown in SEQ ID NO.2;

[0022] The sense strand sequence of the siRNA is shown in SEQ ID NO.11, and the antisense strand sequence of the siRNA is shown in SEQ ID NO.12.

[0023] The beneficial effects of the present invention are:

[0024] The present invention successfully identified the circular RNA circCOQ3 of Huaxi cattle derived from the COQ3 gene, providing an innovative target for skeletal muscle development research and promoting the improvement of beef cattle breeds. Functional studies have shown that circCOQ3 can effectively regulate the proliferation of bovine skeletal muscle cells, and interfering with circCOQ3 will significantly reduce the proliferation efficiency of bovine skeletal muscle primary cells. This discovery provides a new research direction for regulating the proliferation and cell cycle of Huaxi cattle skeletal muscle cells, and opens up new ideas for the research and development of breeding regulators. At the same time, the present invention provides a solid theoretical basis for the application of circCOQ3 in improving the quality of Huaxi cattle beef, making it a potential new target in beef cattle biological breeding. BRIEF DESCRIPTION OF THE DRAWINGS

[0025] Figure 1 is the identification result of bovine circCOQ3 in the present invention;

[0026] Among them, A is the verification of amplifying circCOQ3 with convergent and divergent primers; B is the confirmation of the reverse splicing junction sequence of circCOQ3 by Sanger sequencing; C is the expression level of circCOQ3 and β-actin after RNase R treatment; D is the temporal expression map of circCOQ3; in the figure, * indicates significant difference, ** indicates extremely significant difference;

[0027] Figure 2 The expression of circCOQ3 in the nucleus and cytoplasm of bovine skeletal muscle cells;

[0028] Among them, A is the detection result of fluorescence in situ hybridization, and B is the detection result of nuclear-cytoplasmic separation;

[0029] Figure 3 The interference effect of siRNA of circCOQ3 and the effect of interference of circCOQ3 on the cell cycle of bovine skeletal muscle cells; in the figure, * indicates significant difference, ** indicates extremely significant difference;

[0030] Among them, A is the interference effect of different siRNAs on circCOQ3, B is the effect of interfering with circCOQ3 on different cell cycle genes, and C is the flow cytometry detection result of the cell cycle after interfering with circCOQ3;

[0031] Figure 4 The effect of interfering with circCOQ3 on cell proliferation of bovine skeletal muscle cells; in the figure, * indicates significant difference. DETAILED DESCRIPTION

[0032] The following will be combined with the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without making creative work are within the scope of protection of the present invention.

[0033] The inventors previously conducted circRNA sequencing of the longissimus dorsi muscle tissue of three developmental stages of Huaxi cattle (newborn (NB), young (YG), and adult (AD)), and screened for circCOQ3, which was differentially expressed during muscle development. Therefore, the present invention studies the biological identification method of circCOQ3 and its proliferation effect in bovine skeletal muscle cells, providing a theoretical basis for circCOQ3 as a new target in beef cattle biological breeding.

[0034] The main sources of reagents involved in the present invention are as follows: DMEM low-glucose medium (Gibco, USA), fetal bovine serum (FBS) and horse serum (HS) (Gibco, USA), penicillin-streptomycin double antibody solution (Gibco, USA), PBS solution (Hyclone), pancreatin (Gibco, USA), liposome 3000 reagent (Invitrogen, USA), trizol (Invetrogen), PrimeScript TM RT reagent Kit with gDNA Eraser (Perfect Real Time) (Dalian Takara), qPCR quantification kit (Dalian Takara), blood genomic DNA extraction kit (Tiangen), FISH probe (Guangzhou Ruibo), Edu kit (Guangzhou Ruibo), nucleocytoplasmic separation kit (Norgen), CCK8 proliferation kit (Biyuntian), cell cycle detection kit (Biyuntian), RNase R (lucigen).

[0035] Example 1

[0036] Obtaining cDNA of the longissimus dorsi muscle tissue of three developmental stages (newborn (NB), young (YG), and adult (AD)) of Huaxi cattle

[0037] ATotal RNA extraction and quality testing

[0038] (1) The longissimus dorsi muscle tissue (from Inner Mongolia Aokos Animal Husbandry Co., Ltd.) was ground with liquid nitrogen, and then an appropriate amount of TRIzol was added and placed at room temperature for 3 min to lyse the cells:

[0039] (2) Add 200 μL of chloroform per mL of TRIzol, shake vigorously for 20 seconds, and let stand at room temperature for 5 minutes;

[0040] (3) Centrifuge at 12000g for 10 min at 4°C:

[0041] (4) Pipette the supernatant into a new centrifuge tube, add 500 μL of isopropanol per mL of TRIzol, mix by inverting, and let stand at room temperature for 10 min;

[0042] (5) Centrifugation at 12,000 g for 10 min at 4°C;

[0043] (6) Discard the supernatant. A small amount of white RNA precipitate can be seen at the bottom of the tube. Wash the precipitate with 75% ethanol, centrifuge at 7500 g for 5 min at 4°C, discard the supernatant, and repeat the wash process.

[0044] (7) Allow the precipitate to air dry for 5 min. When the white precipitate begins to turn translucent, add 30 μL of nuclease-free water, shake to mix, and store on ice for a short period of time.

[0045] (8) Determine the concentration and purity of RNA using a spectrophotometer and store at -80°C. After extraction, use NanoDrop2000 to detect the concentration and OD value of total RNA. The OD260 / 280 ratio of RNA should be between 1.8 and 2.0 to ensure that there is no protein or phenol contamination and no degradation.

[0046] B cDNA synthesis

[0047] According to Takara's reverse transcription kit PrimeScript TM RT reagent Kit with gDNA Eraser to synthesize the first strand of cDNA:

[0048] (1) To remove genomic DNA, the reaction system and conditions are as follows:

[0049]

[0050]

[0051] Reaction conditions: 42°C, 2 min; 4°C forever.

[0052] (2) circRNA reverse transcription, the reverse transcription system and conditions are as follows:

[0053]

[0054] Reaction conditions: 37℃ for 15min; 85℃ for 5sec; 4℃ forever.

[0055] Example 2

[0056] Obtaining genomic DNA from the longissimus dorsi muscle tissue of three developmental stages (newborn (NB), young (YG), and adult (AD)) of Huaxi cattle

[0057] (1) Take part of the tissue and grind it into powder using liquid nitrogen;

[0058] (2) Take an appropriate amount of tissue powder, add 200 μl of buffer GB and 20 μl of proteinase K premix solution to the 200 μl sample obtained by the above treatment, mix thoroughly by inversion, and place at 56°C for 10 min, inverting and mixing several times during the process, until the solution becomes clear.

[0059] (3) After standing at room temperature for 2-5 min, add 350 μl of buffer BD and mix thoroughly by inverting. Flocculent precipitate may appear at this time.

[0060] (4) Add the solution and flocculent precipitate obtained in the previous step to an adsorption column CG2 (adsorption column CG2 is placed in a collection tube), centrifuge at 12000 rpm for 30 seconds, pour out the waste liquid in the collection tube, and place the adsorption column CG2 in the collection tube.

[0061] (5) Add 500 μl of buffer GDB to the adsorption column CG2, centrifuge at 12,000 rpm for 30 seconds, pour out the waste liquid in the collection tube, and place the adsorption column CG2 in the collection tube.

[0062] (6) Add 600 μL of rinse solution PWB to adsorption column CG2 (please check whether anhydrous ethanol has been added before use), centrifuge at 12,000 rpm for 30 seconds, pour out the waste liquid in the collection tube, and place adsorption column CG2 in the collection tube.

[0063] (7) Repeat step 6.

[0064] (8) Centrifuge at 12000 rpm for 2 min, discard the waste liquid, and place the adsorption column CG2 at room temperature for 2 min to completely dry the residual rinse liquid in the adsorption material.

[0065] (9) Transfer the adsorption column CG2 into a 1.5 ml centrifuge tube, add 50-200 μl of elution buffer TB to the middle of the adsorption membrane, leave it at room temperature for 2 min, centrifuge it at 12,000 rpm for 2 min, collect the solution into a centrifuge tube, and obtain genomic DNA.

[0066] Example 3

[0067] The longissimus dorsi muscle tissue of young Huaxi cattle was selected for RT-PCT reaction and agarose gel electrophoresis

[0068] The transcript sequence of circCOQ3 is shown as SEQ ID NO.1, and the circCOQ3 connection sequence is shown as SEQ ID NO.2.

[0069] The upstream primer sequence of the divergent primer designed according to the transcript sequence of circCOQ3 is: ACCTGGGAGAAGTTTGTTTCAC, SEQ ID NO.3; the downstream primer sequence of the divergent primer is: CATCCAATTCAGGCAGGCAA, SEQ ID NO.4;

[0070] The upstream primer sequence of the convergent primer designed according to the transcript sequence of circCOQ3 is: CTTGGGGCTTCAGTCATTGG, SEQ ID NO.5; the downstream primer sequence of the convergent primer is: ACACTTGAAAGCAGCACTGT, SEQ ID NO.6.

[0071] RT-PCR

[0072] (1) The reaction system of RT-PCR is as follows: 15 μL of 2× Master Mix Taq enzyme, 1 μL of cDNA template, 0.8 μL of upstream and downstream primers, and sterile ddH2O to 30 μL.

[0073] (2) The reaction conditions were: 95°C, 5 min; 95°C, 30 s; optimal Tm 30 s; 72°C, 30 s, 36 cycles; 72°C, 5 min; and storage at 4°C.

[0074] Agarose gel electrophoresis

[0075] (1) Prepare a 2% agarose gel containing nucleic acid dye, apply 120 V voltage and perform electrophoresis for 30 min after spotting samples;

[0076] (2) When the fragments are clearly separated, image them using the BIO-RAD Gel Doc 2000 gel imaging system;

[0077] (3) Analyze the sequence length of the amplified product based on the comparison of the marker and fragment band positions in agarose gel electrophoresis imaging.

[0078] The results are as follows Figure 1 -A, from Figure 1It can be seen that using bovine longissimus dorsi cDNA as a template, circCOQ3divergent primer can successfully amplify the product, but when using bovine longissimus dorsi gDNA as a template, circCOQ3divergent primer cannot amplify the product; using bovine longissimus dorsi cDNA as a template, circCOQ3 convergentprimer can successfully amplify the product, and when using bovine longissimus dorsi gDNA as a template, circCOQ3 convergentprimer can amplify the product.

[0079] Example 4

[0080] Perform Sanger sequencing

[0081] (1) Cut the successfully identified fragment from the gel, place it in a clean centrifuge tube, and weigh it.

[0082] (2) Add an equal volume of PC solution to the gel block and place it in a 50°C water bath for about 10 min. During this time, gently invert the centrifuge tube up and down to ensure that the gel block is fully dissolved.

[0083] (3) Add the solution obtained in the previous step to an adsorption column CB2 (the adsorption column is placed in a collection tube), centrifuge at 12,000 rpm for 1 min, pour out the waste liquid in the collection tube, and place the adsorption column CB2 in the collection tube.

[0084] (4) Add 600 μl of rinse solution PW to the adsorption column CB2, centrifuge at 12,000 rpm for 1 min, pour out the waste liquid in the collection tube, and place the adsorption column CB2 in the collection tube.

[0085] (5) Repeat step 4.

[0086] (6) Place the adsorption column CB2 in a collection tube and centrifuge at 12,000 rpm for 2 min to remove as much of the rinse solution as possible. Leave the adsorption column at room temperature for several minutes to dry thoroughly.

[0087] (7) Place the adsorption column CB2 in a clean centrifuge tube, add an appropriate amount of elution buffer EB to the middle of the adsorption membrane, leave it at room temperature for 2 minutes, centrifuge it at 12,000 rpm (~13,400 x g) for 2 minutes, and collect the DNA solution.

[0088] (8) The DNA solution is sent to Sangon Biotechnology Co., Ltd. for Sanger sequencing to check the sequencing results to see whether the circularization site is amplified. If the circularization site is amplified, it is confirmed to be circular RNA.

[0089] from Figure 1-B results show that Sanger sequencing detected the real circularization site, proving that circCOQ3 has a reverse splicing connection, but no genomic rearrangement.

[0090] Example 5

[0091] RNase R resistance test

[0092] Total RNA (1 mg) from bovine longissimus dorsi muscle was treated with 2 U / mg RNaseR at 37°C for 20 minutes. The treated RNA was reverse transcribed into cDNA for subsequent fluorescence quantitative PCR experimental verification.

[0093] The results are as follows Figure 1 -C, from Figure 3 It can be seen that circCOQ3 has stronger resistance than the linear mRNA control ( Figure 1 C), which confirmed that circCOQ3 is a bona fide circRNA.

[0094] Example 6

[0095] Fluorescence quantitative PCR and sequencing were used to detect the expression of circCOQ3 in the longissimus dorsi muscle tissue of Huaxi cattle at three developmental stages (newborn (NB), young (YG), and adult (AD)).

[0096] (1) The primer sequence of circCOQ3 was the same as that of Example 3. The upstream primer sequence of GAPDH was ATCCTGCCAACATCAAGTGG, as shown in SEQ ID NO.7, and the downstream primer sequence of GAPDH was TCACGCCCATCACAAACATG, as shown in SEQ ID NO.8.

[0097] (2) Fluorescence quantitative PCR reaction system is as follows:

[0098]

[0099] (3) Fluorescence quantitative PCR reaction conditions: 95°C, 30 s; 95°C, 5 s, 60°C, 34 s; 95°C, 15 s, 60°C, 1 min, 95°C, 15 s, for a total of 40 cycles.

[0100] from Figure 1 -D results show that circRNA-seq and qPCR data show that circCOQ3 has a relatively consistent expression trend in the three stages, and the expression level of circCOQ3 decreases with age.

[0101] Example 7

[0102] Detection of circCOQ3 expression in the cytoplasm and nucleus of bovine skeletal muscle cells

[0103] Fluorescence in situ hybridization

[0104] 1. Cell Culture

[0105] Place the cell slides at the bottom of a 24-well plate and culture an appropriate amount of cells. Before the experiment, the cell confluence should reach 60%-70%.

[0106] 2. Cell Fixation and Permeabilization

[0107] a. Wash cells with 1X PBS for 5 minutes;

[0108] b. Fix with 4% paraformaldehyde at room temperature for 10 minutes;

[0109] c. Wash cells with 1X PBS for 5 minutes, 3 times;

[0110] d. Add 1 mL of pre-cooled permeabilization solution to each well and incubate at 4°C for 5 min.

[0111] e. After discarding the permeabilization solution, add 1X PBS to wash the cells for 5 minutes, three times.

[0112] 3. Probe detection

[0113] a. Add 200uL pre-hybridization solution to each well and block at 37℃ for 30min;

[0114] b. During prehybridization, preheat the hybridization solution at 37°C;

[0115] c. In the dark, add 2.5uL 20uM circRNA FISH Probe Mix storage solution or internal reference FISH Probe Mix storage solution to 100μl hybridization solution;

[0116] d. Discard the pre-hybridization solution in each well of cells, add 100uL of probe hybridization solution containing the probe, protect from light, and hybridize at 37°C overnight;

[0117] e. Wash each well of cells three times at 42°C with hybridization wash solution I, protected from light, for 5 min each time, to reduce background signals;

[0118] f. Wash the cells once in the dark at 42°C with Hybridization Wash Solution II;

[0119] g. Wash the cells once in the dark at 42°C with hybridization wash solution III;

[0120] h. Protect from light, wash cells with 1X PBS at room temperature for 5 minutes.

[0121] 4.DNA staining

[0122] a. Protect from light, stain with 1X DAPI staining solution for 10 minutes. The amount of staining solution should be enough to cover all cells in the hybridization area;

[0123] b. Protect from light and wash the cells three times with 1X PBS, 5 min each time.

[0124] 5. Seal the slide

[0125] Under light-proof conditions, carefully remove the cell slides from the wells, fix them on glass slides with mounting media, and examine them using a confocal microscope.

[0126] B. Nuclear and cytoplasmic separation

[0127] (1) Preparation of cell components

[0128] a. Aspirate the culture medium and rinse the cells with an appropriate amount of PBS. Aspirate the PBS.

[0129] b. Add 200uL of pre-chilled Lysis Buffer J directly to the culture plate.

[0130] c. Place the cell culture dish on ice and lyse the cells for five minutes by gently tapping the dish and swirling the buffer over the surface of the dish.

[0131] d. Use a pipette to transfer the lysate to an RNase-free centrifuge tube and spin the lysate at maximum speed in a benchtop centrifuge for 10 minutes.

[0132] e. Using a small-tip pipette, transfer the supernatant containing the cytoplasmic RNA to another RNase-free tube.

[0133] Another RNase-free tube (not provided). See Important Note below. If nuclear RNA extraction is desired, retain the pellet containing the nuclear RNA.

[0134] (2) Binding of cytoplasmic RNA to the column

[0135] a. Add 200uL of buffer SK to the supernatant (cytoplasmic RNA fraction) in step 1e and mix by vortexing for 10 seconds.

[0136] b. Add 200uL 96-100% ethanol to the mixture and shake for 10 seconds.

[0137] c. Place the mixture onto a spin column equipped with a collection tube and centrifuge at ≥3500 x g (~6000 RPM) for 1 minute.

[0138] d. Discard the liquid. Reassemble the spin column with its collection tube.

[0139] (3) Binding of nuclear RNA to the column

[0140] a. Add 400uL of buffer SK from step 1e to the pellet (nuclear RNA fraction) and vortex to mix for 10 seconds.

[0141] b. Add 200uL 96-100% ethanol to the mixture and shake for 10 seconds.

[0142] c. Place the mixture onto a second spin column assembled with a collection tube and centrifuge at ≥3500 x g (~6000 RPM) for 1 minute.

[0143] d. Discard the liquid. Reassemble the spin column with its collection tube.

[0144] (4) Column washing

[0145] a. Add 400 μL Wash Solution A to the column, centrifuge for 1 minute, and discard the liquid.

[0146] b. Repeat step 3a.

[0147] c. Wash the column for the third time by adding 400 μL of washing solution A and centrifuging for 1 minute.

[0148] d. Discard the liquid and reassemble the spin column into the collection tube.

[0149] e. Centrifuge for 2 minutes to completely dry the resin. Discard the collection tube.

[0150] (5) RNA elution

[0151] a. Place the adsorption column into the 1.7 mL elution tube provided with the kit.

[0152] b. Add 50 μL of elution buffer E to the adsorption column.

[0153] c. Centrifuge at 200 x g (~2000 RPM) for 2 minutes, then centrifuge at 14000 x g for 1 minute

[0154] (6) RNA storage

[0155] Purified RNA samples can be stored at -20℃ for several days. It is recommended to store samples at -70℃ for long-term storage.

[0156] C. Reverse transcription and real-time fluorescence quantitative PCR of RNA obtained from cytoplasm and nucleus

[0157] The steps are the same as those in the above embodiment, except that the nuclear RNA internal reference is U6, the upstream primer of U6 is GCTTCGGCAGCACATATACTAAAAT, SEQ ID NO.9; the downstream primer of U6 is CGCTTCACGAATTTGCGTGTCAT, SEQ ID NO.10.

[0158] from Figure 2 From the results of A, it can be seen that circCOQ3 fluorescence staining is concentrated in the cytoplasm, and the results of PCR also show that the expression of circCOQ3 is concentrated in the cytoplasm, so circCOQ3 is mainly distributed in the cytoplasm.

[0159] Example 8

[0160] Effect of circCOQ3 on the proliferation of bovine skeletal muscle cells

[0161] siRNA was designed according to the transcript sequence of circCOQ3. The sense strand sequence of si-circCOQ3-1 was GCAUUCUGGAAUCAAUUUA, as shown in SEQ ID NO.11, and the antisense strand was: UAAAUUGAUUCCAGAAUGC, as shown in SEQ ID NO.12;

[0162] The sense strand sequence of si-circCOQ3-2 is CUGGAAUCAAUUUAUCCAA, as shown in SEQ ID NO.13, and the antisense strand is: UUGGAUAAAUUGAUUCCAG, as shown in SEQ ID NO.14;

[0163] The sense strand sequence of si-circCOQ3-3 is: GGAAUCAAUUUAUCCAAAG, as shown in SEQ ID NO.15, and the antisense strand is CUUUGGAUAAAUUGAUUCC, as shown in SEQ ID NO.16.

[0164] A cell transfection

[0165] (1) Dilute the above siRNA to 50 μM with nuclease-free water, store in aliquots in a -80°C refrigerator for later use;

[0166] (2) Bovine skeletal muscle cells were seeded into 12-well plates and placed in an incubator until the cells were completely attached;

[0167] (3) Take two 1.5 mL centrifuge tubes, add 50 μL serum-free low-glucose DMEM and 2.5 μL siRNA to one centrifuge tube, and add 50 μL serum-free low-glucose DMEM and 2.5 μL liposomes to the other centrifuge tube. Mix them well, then mix the two tubes together, gently mix, and incubate at room temperature for 5 min.

[0168] (4) Add the incubated mixture to complete culture medium, mix gently, add to cells for culture, and perform subsequent treatment after 48 hours of culture.

[0169] B. Total RNA extraction, cDNA synthesis and fluorescence quantitative PCR are the same as in the above example

[0170] First, the inhibitory effects of different si-circCOQ3 were detected, and the results were as follows Figure 3 As shown in A, it can be seen that si-circCOQ3-1 has the best inhibitory effect, so si-circCOQ3-1 was used as siRNA for circCOQ3 in subsequent experiments.

[0171] Then, the effect of interfering with circCOQ3 on cell cycle genes was detected, and the results were as follows Figure 3 As shown in B.

[0172] Among them, the upstream primer sequence of CDKN1A gene is AAACGGCGGCAGACC, SEQ ID NO.17, and the upstream primer sequence of CDKN1A gene is GCCCAAGGCAAAAGG, SEQ ID NO.18;

[0173] The upstream primer sequence of Cyclin D1 gene is GACGAGCTGCTGCACATGGA, SEQ ID NO.19, and the downstream primer sequence of CyclinD1 gene is TGCTTGTTCTCCTCGGCCAC, SEQ ID NO.20;

[0174] The upstream primer sequence of the PCNA gene is GCTGTGTAGTAAAGATGCCT, SEQ ID NO.21, and the upstream primer sequence of the PCNA gene is ATCTCTATGGCAACAGCTTC, SEQ ID NO.22.

[0175] from Figure 3 As can be seen from B, after interfering with circCOQ3, the cell cycle inhibitory gene CDKN1A was significantly upregulated, and the cell cycle promoting genes Cyclin D1 and PCNA were significantly downregulated, indicating that inhibiting circCOQ3 can effectively inhibit the cell cycle of bovine skeletal muscle cells.

[0176] C. Flow cytometry for cell cycle detection

[0177] (1) Cell culture and treatment: Logarithmic phase bovine skeletal muscle cells were inoculated into a medium cell culture dish and transfected when the cell density reached about 50%. When the cell confluence reached about 80%, the cells were digested with trypsin and collected into a 2 mL centrifuge tube. The cells were washed twice with PBS.

[0178] (2) Cell fixation: After washing the cells with PBS, centrifuge and discard the supernatant, add pre-cooled 70% ethanol and fix at 4°C overnight.

[0179] (3) Cell staining: Collect cells by centrifugation, wash cells twice with 1 mL of PBS, add 500 uL of PI staining solution (PBS containing 50 μg / mL propidium iodide (PI), 100 μg / mL RNase A, 0.2% TritonX-100), and incubate at 4°C in the dark for 30 minutes.

[0180] (4) Flow cytometry was used to count 20,000 to 30,000 cells, and the data were analyzed using cell cycle simulation software.

[0181] The results are as follows Figure 3 As shown in C, it can be seen that the number of cells in the S phase is significantly reduced, which once again verifies that interfering with circCOQ3 can effectively inhibit the cell cycle of bovine skeletal muscle cells.

[0182] Example 9

[0183] Effects of circCOQ3 interference on bovine skeletal muscle cell proliferation

[0184] (1) Skeletal muscle cells were added to 96-well plates. After the cells were completely attached, the control group was transfected with si-NC, and the treatment group was transfected with si-circCOQ3;

[0185] (2) 48 h after transfection, the culture medium was discarded, and the cells were fixed with 4% paraformaldehyde solution for 30 min. The paraformaldehyde solution was discarded, and the excess paraformaldehyde solution in the wells was neutralized with 2 mg / mL glycine solution. PBS was added for washing three times, each time for 5 min;

[0186] (3) Add 0.5% TritonX-100 permeabilization agent and incubate on a decolorizing shaker for 10 min, then wash once with PBS;

[0187] (4) Add the Apollo staining solution prepared in advance, incubate on a shaker for 30 minutes in a dark environment, discard the staining solution, wash three times with PBS, and finally add DAPI to stain the nucleus. Then, take pictures under a fluorescence microscope to compare the changes in the number of positive cells in the control group and the treatment group.

[0188] from Figure 4 The results showed that compared with the control group, the number of positive cells in the si-circCOQ3 transfected group was significantly reduced, indicating that interfering with circCOQ3 can effectively inhibit the proliferation of bovine skeletal muscle cells.

Claims

1. A circular RNA associated with skeletal muscle development in Huaxi cattle, It is characterized in that The circular RNA is circCOQ3, the transcript sequence of the circCOQ3 is shown as SEQ ID NO.1, and the connecting gene sequence of the circCOQ3 is shown as SEQ ID NO.

2.

2. Application of primers for detecting circular RNA circCOQ3 expression in the preparation of a kit for detecting the skeletal muscle development stage of Huaxi cattle, It is characterized in that The transcript sequence of circCOQ3 is shown in SEQ ID NO.1, and the connecting gene sequence of circCOQ3 is shown in SEQ ID NO.2; The sequences of the primers are shown in SEQ ID NO.3 and SEQ ID NO.

4.

3. The use according to claim 2, It is characterized in that The Huaxi cattle skeletal muscle is the longissimus dorsi muscle of Huaxi cattle.

4. The use according to claim 2, It is characterized in that The expression level of circular RNA circCOQ3 in the skeletal muscle of newborn Huaxi cattle was the highest, while the expression level of circular RNA circCOQ3 in the skeletal muscle of adult Huaxi cattle was the lowest.

5. Application of inhibitors interfering with the expression of circular RNA circCOQ3 in the preparation of breeding regulators for skeletal muscle improvement of Huaxi cattle, It is characterized in that The transcript sequence of circCOQ3 is shown in SEQ ID NO.1, and the connecting gene sequence of circCOQ3 is shown in SEQ ID NO.

2.

6. The use according to claim 5, It is characterized in that The inhibitor is siRNA, the sense strand sequence of the siRNA is shown in SEQ ID NO.11, and the antisense strand sequence of the siRNA is shown in SEQ ID NO.

12.

7. The use according to claim 6, It is characterized in that The inhibitor regulates the skeletal muscle improvement breeding of Huaxi cattle by regulating the proliferation of skeletal muscle cells of Huaxi cattle.

8. Application of inhibitors interfering with the expression of circular RNA circCOQ3 in the preparation of inhibitors for inhibiting the proliferation of skeletal muscle cells of Huaxi cattle, It is characterized in that The transcript sequence of circCOQ3 is shown in SEQ ID NO.1, and the connecting gene sequence of circCOQ3 is shown in SEQ ID NO.2; The inhibitor is siRNA, the sense strand sequence of the siRNA is shown in SEQ ID NO.11, and the antisense strand sequence of the siRNA is shown in SEQ ID NO.

12.

9. Application of inhibitors interfering with the expression of circular RNA circCOQ3 in the preparation of preparations for regulating the cell cycle of skeletal muscle cells of Huaxi cattle, It is characterized in that The transcript sequence of circCOQ3 is shown in SEQ ID NO.1, and the connecting gene sequence of circCOQ3 is shown in SEQ ID NO.2; The inhibitor is siRNA, the sense strand sequence of the siRNA is shown in SEQ ID NO.11, and the antisense strand sequence of the siRNA is shown in SEQ ID NO.12; The cell cycle inhibitor leads to a significant upregulation of the cell cycle inhibitory gene CDKN1A and a significant downregulation of the cell cycle promoting genes Cyclin D1 and PCNA.

10. A method for inhibiting the proliferation of skeletal muscle cells of Huaxi cattle, It is characterized in that The method comprises the following steps: (1) Inoculating Huaxi cattle skeletal muscle cells into a cell culture device, placing them in a cell culture incubator, and culturing them until they adhere to the wall; (2) Transfecting siRNA of circular RNA circCOQ3 into cells and continuing to culture them in a cell culture incubator can inhibit the proliferation of Huaxi cattle skeletal muscle cells; The transcript sequence of circCOQ3 is shown in SEQ ID NO.1, and the connecting gene sequence of circCOQ3 is shown in SEQ ID NO.2; The sense strand sequence of the siRNA is shown in SEQ ID NO.11, and the antisense strand sequence of the siRNA is shown in SEQ ID NO.12.

Citation Information

Patent Citations

  • Biological identification method and application of bovine skeletal muscle development related circular RNA circMYH8

    CN114807135A

  • Engineered circular RNA circmir-29b and use thereof in preparation of medicine for treating muscle atrophy

    US20220403384A1